Concepedia
Statistics
Publications
23
Citations
1.3K
H-Index
17
Active since
2004
Affiliations
Vanderbilt University(Current)
VA Tennessee Valley Healthcare System
Regeneron (United States)
Pfizer (United States)
AstraZeneca (United States)
Mohamed Hassanein is an author at Vanderbilt University specializing in oncology, medicine, and molecular oncology.
Publications per year
2004–2024
SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Mohamed Hassanein, Megan D. Hoeksema, Masakazu Shiota et al. · Clinical Cancer Research · 2012 · 352 citations
Life Sciences, Molecular Biology, Oncology +14
Targeting <scp>SLC1a5</scp>‐mediated glutamine dependence in non‐small cell lung cancer
Mohamed Hassanein, Jun Qian, Megan D. Hoeksema et al. · International Journal of Cancer · 2015 · 164 citations · Full text
Medicine, Oncology, Pharmacology +13
The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers
Jun Qian, Mohamed Hassanein, Megan D. Hoeksema et al. · Proceedings of the National Academy of Sciences · 2015 · 101 citations · Full text
Medicine, Molecular Biology, Oncology +17
Comparison of efficacy of<i>Salmonella typhimurium</i>A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells
Yukihiko Hiroshima, Ming Zhao, Yong Zhang et al. · Cell Cycle · 2013 · 79 citations · Full text
Medicine, Oncology, Pharmacology +14
Moesin expression is a marker of basal breast carcinomas
Emmanuelle Charafe‐Jauffret, Florence Monville, François Bertucci et al. · International Journal of Cancer · 2007 · 78 citations · Full text
1–5 of 23